“ú–{–òŠw‰ï ‘æ136”N‰ïi‰¡•lj@2016”N3ŒŽ26“ú(“y)E27“ú(“ú)E28“ú(ŒŽ)E29“ú(‰Î)@–k—¢‘åŠw–òŠw•” Œö‰vŽÐ’c–@l “ú–{–òŠw‰ï Œö‰vŽÐ’c–@l “ú–{–òŠw‰ï Œö‰vŽÐ’c–@l “ú–{–òŠw‰ï FAQ

3ŒŽ27“ú(æ—¥)@9:00~11:00@C‰ïê パシフィコ横浜 会議センター 3F 302
S02
医薬å“ã«ã‚ˆã‚‹æœ‰å®³äº‹è±¡0(ゼロ)ã¸ã®æŒ‘戦 ~日本医薬å“安全性学会設立を起点ã¨ã—ã¦ï½ž
Challenge to Turn Adverse Drug Event into a Zero ~Starting from the Establishment of Japanese Society of Drug Safety~
オーガナイザー:宇野 å‹æ¬¡ã€å‰ç”° 頼伸

S02-1
日本医薬å“安全性学会ãŒæå”±ã™ã‚‹ã€Œè¢«ç–‘薬剤ã¨æœ‰å®³äº‹è±¡ã®é–¢é€£åº¦è©•ä¾¡åŸºæº–ã€ã¨ã€Œå‰¯ä½œç”¨é‡ç¯¤åº¦ï¼ˆã‚°ãƒ¬ãƒ¼ãƒ‰ï¼‰åˆ¤å®šåŸºæº–ã€
“Criteria for the relation degree between suspected drugs and AE†and “Criteria for seriousness (grade of severity) of ADR†Advocated by Japanese Society of Drug Safety
ƒVƒ“ƒ|ƒWƒXƒg F ○齊藤 幹央

S02-2
アレルギー性副作用ã®ç™ºç—‡æ©Ÿåºã€èª˜ç™ºè¦å› ãŠã‚ˆã³å›žé¿å¯¾ç­–ã®æ¤œè¨Žã®æœ‰ç”¨æ€§
Utility studying developmental the mechanisms, induction factors and prevention measures in allergic side effects of drug
ƒVƒ“ƒ|ƒWƒXƒg F ○宇野 å‹æ¬¡

S02-3
中毒性副作用ã®ç™ºç—‡æ©Ÿåºã€èª˜ç™ºè¦å› ãŠã‚ˆã³å›žé¿å¯¾ç­–ã®æ¤œè¨Žã®æœ‰ç”¨æ€§ï½žç‰¹ã«æ…¢æ€§è…Žè‡“ç—…ã«ç€ç›®ã—ã¦ï½ž
Utility studying development of the mechanisms, induction factors and prevention measures in toxic side effects of drug. —Especially forcusing chronic kidney disease—
ƒVƒ“ƒ|ƒWƒXƒg F ○平田 純生

S02-4
病院薬剤師ã«ã‚ˆã‚‹åŒ»è–¬å“ã®å®‰å…¨æ€§ã¸ã®å–り組ã¿
The approach to drug safety by hospital pharmacists
ƒVƒ“ƒ|ƒWƒXƒg F â—‹é‡Žæ‘ å‰›ä¹…

S02-5
薬局薬剤師ã«ã‚ˆã‚‹åŒ»è–¬å“ã®å®‰å…¨æ€§ã¸ã®å–り組ã¿
The approach to drug safety by pharmacy pharmacists
ƒVƒ“ƒ|ƒWƒXƒg F ○神浦 茉奈実ã€å±±æœ¬ 京ã€å»£ç”° 憲å¨

ŒŸõƒy[ƒW‚É–ß‚é

TOP‚Ö–ß‚é
ƒvƒ‰ƒCƒoƒV[ƒ|ƒŠƒV[‚ɂ‚¢‚Ä
@Copyright (C) Œö‰vŽÐ’c–@l“ú–{–òŠw‰ï